Notable Ups And Down: PTC Inc. (NASDAQ:PTC), Pfizer Inc. (NYSE:PFE), Cardinal Health, Inc. (NYSE:CAH), Symetra Financial Corporation (NYSE:SYA), Sonic Corp. (NASDAQ:SONC)

PTC Inc. (NASDAQ:PTC) on Wednesday reported fiscal first-quarter profit of $30.3 million. On a per-share basis, the Needham, Massachusetts-based company said it had net income of 26 cents. Earnings, adjusted for one-time gains and costs, were 50 cents per share. PTC Inc. (NASDAQ:PTC) belongs to Technology sector. Its net profit margin is 11.80% and weekly performance is -2.77%. On last trading day company shares ended … Continue reading Notable Ups And Down: PTC Inc. (NASDAQ:PTC), Pfizer Inc. (NYSE:PFE), Cardinal Health, Inc. (NYSE:CAH), Symetra Financial Corporation (NYSE:SYA), Sonic Corp. (NASDAQ:SONC)

Mid Cap Unusal Volume: First Citizens BancShares (NASDAQ:FCNCA), Houghton Mifflin Harcourt (NASDAQ:HMHC), Washington Federal (NASDAQ:WAFD), PTC (NASDAQ:PTC), Harsco (NYSE:HSC)

The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of First Citizens Bancorporation, Inc (OTCMKTS:FCBN) shares, was launched concerning whether the takeover of First Citizens Bancorporation, Inc by First Citizens BancShares (NASDAQ:FCNCA), Inc is unfair to First Citizens Bancorporation stockholders. First Citizens BancShares Inc. (NASDAQ:FCNCA) stock performance was -0.62% in last session and finished the day at $247.65. Traded … Continue reading Mid Cap Unusal Volume: First Citizens BancShares (NASDAQ:FCNCA), Houghton Mifflin Harcourt (NASDAQ:HMHC), Washington Federal (NASDAQ:WAFD), PTC (NASDAQ:PTC), Harsco (NYSE:HSC)

Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) presented results from a global, multi-center, open-label, comparator-controlled phase II study in patients undergoing total knee replacement surgery or total knee arthroplasty (TKA). Two doses of ISIS-FXIRx (200mg, 300mg) were compared to Sanofi’s Lovenox (enoxaparin). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock performance was 11.26% in last session and finished the day at $27.81. Traded volume was 4,554,523 shares in the last session … Continue reading Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)